Finance

Lists
NRC:NASDAQ
NRC Health
24,26 USD
+1,80%
(+0,43) 1D
24,26 USD
0,00% (0,00)
After hours
Closed: 2-ноя., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRC...
Open
24,02 USD
High
24,69 USD
Low
23,84 USD
Mkt. cap
514,83 млн
Avg. vol.
103,00 миң
Volume
101,20 миң
Dividend
2,64%
Quarterly dividend
0,16 USD
Ex-dividend date
2026-ж., 25-сен.
P/E ratio
86,30
52-wk high
24,69 USD
52-wk low
11,74 USD
EPS
0,28 USD
Beta
0,25
Shares outstanding
22,12 млн
No. of employees
357
Open
24,02 USD
High
24,69 USD
Low
23,84 USD
Mkt. cap
514,83 млн
Avg. vol.
103,00 миң
Volume
101,20 миң
Dividend
2,64%
Quarterly dividend
0,16 USD
Ex-dividend date
2026-ж., 25-сен.
P/E ratio
86,30
52-wk high
24,69 USD
52-wk low
11,74 USD
EPS
0,28 USD
Beta
0,25
Shares outstanding
22,12 млн
No. of employees
357
News stories
From web sources and news partners
Profile
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska. The company changed its corporate name from National Research Corporation to NRC Health, Inc. in April 2026. Wikipedia
About NRC Health
CEOMichael Hays
Employees357
Founded1981
HeadquartersЛинкольн, Небраска, Америка Кошмо Штаттары
SectorHealth care provider
Analyst ratings
Based on 1 analyst giving stock ratings to NRC in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for NRC in the last 3 months
Highest
Current 24,26 USD
27,00 USD (+11,29%)
Average
27,00 USD (+11,29%)
Lowest
27,00 USD (+11,29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Constantine Davides
Citizens JMP
Buy
Maintained
27,00 USD
+11,3%
10/28/2026
Last report
2026-ж., 27-окт.
Fiscal period
Q3 2026
0,21 USD / 0,18 USD
+16,67%beat
Revenue / Est. (USD)
38,40 млн / 35,80 млн
+7,26%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
35,19 млн
34,80 млн
35,39 млн
38,40 млн
Cost of goods sold
13,94 млн
13,65 млн
13,56 млн
15,38 млн
Cost of revenue
13,94 млн
13,65 млн
13,56 млн
15,38 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,79 млн
13,42 млн
19,78 млн
12,04 млн
Operating expense
9,94 млн
15,59 млн
21,91 млн
14,11 млн
Total operating expenses
23,87 млн
29,23 млн
35,47 млн
29,49 млн
Operating income
11,32 млн
5,57 млн
-78,00 миң
8,91 млн
Other non operating income
-61,00 миң
30,00 миң
2,00 миң
-
EBT including unusual items
3,27 млн
4,38 млн
-4,54 млн
7,40 млн
EBT excluding unusual items
9,92 млн
4,38 млн
-1,38 млн
7,40 млн
Income tax expense
1,47 млн
1,16 млн
-1,25 млн
2,70 млн
Effective tax rate
45,00%
26,42%
27,64%
36,45%
Other operating expenses
-
-
-
-
Net income
1,80 млн
3,22 млн
-3,28 млн
4,70 млн
Net profit margin
5,11%
9,26%
-9,28%
12,25%
Earnings per share
-
-
0,31
0,21
Interest and investment income
29,00 миң
35,00 миң
20,00 миң
26,00 миң
Interest expense
-1,37 млн
-1,26 млн
-1,32 млн
-1,53 млн
Net interest expenses
-1,34 млн
-1,22 млн
-1,30 млн
-1,51 млн
Depreciation and amortization charges
2,14 млн
2,17 млн
2,12 млн
2,07 млн
EBITDA
13,47 млн
7,74 млн
2,04 млн
10,98 млн
Gain or loss from assets sale
61,00 миң
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору